Over the past decade, advances in cancer genetics and oncogenomic have profoundly reshaped our understanding of pediatric tumors. Unlike adult cancers, ...

-- Milestone marks first of multiple planned diagnostic product launches on NGS roadmap -- Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro ...

Oncology leaders appearing in Atlanta, Georgia, including several from Winship Cancer Institute from Emory University School of Medicine, show how NGS biomarkers and MRD reshape NSCLC and hematology ...

IDT's suite of NGS innovations aim to tackle longstanding bottlenecks in library preparation, targeted enrichment, and whole ...

A state-of-the-art high-throughput sequencing device (Next-Generation Sequencing, NGS) is now available at the Keylab Genomics & Bioinformatics of the University of Bayreuth for rapid and ...

The global DNA sequencing market is projected to reach USD 40.02 billion by 2031, driven by declining sequencing costs, expanding clinical applications in oncology and rare diseases, and growing ...

As demand for high-throughput genomic profiling continues to grow, laboratories and research organizations face increasing ...

Next-generation sequencing (NGS) has transformed genomic research and clinical diagnostics by enabling rapid, high-throughput analysis of genetic material. The application of NGS to formalin-fixed ...

The global next generation sequencing market is poised to experience robust expansion, registering an estimated growth rate of around 15% over the next five years. This accelerated growth reflects the ...

Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people ...

SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next ...